CenterStar Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-3,448
Closed -$1.84M – 457
2023
Q2
$1.8M Buy
3,448
+2,942
+581% +$1.59M 0.2% 56
2023
Q1
$292K Buy
+506
New +$285K 0.11% 143
2022
Q2
– Hold
0
– – – 260
2022
Q1
– Hold
0
– – – 446
2021
Q4
– Hold
0
– – – 361
2021
Q2
– Hold
0
– – – 340
2021
Q1
– Hold
0
– – – 375
2020
Q4
– Hold
0
– – – 550
2020
Q3
– Hold
0
– – – 416
2020
Q2
– Hold
0
– – – 527
2018
Q3
– Hold
0
– – – 239
2018
Q1
– Hold
0
– – – 204
2017
Q4
– Hold
0
– – – 340

Other funds holding TMO

CenterStar Asset Management's TMO Position: Q3 2023 in Review

CenterStar Asset Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 3,448 shares — an estimated $1.84M sold.

CenterStar Asset Management first reported a position in TMO in Q1 2023 and held it in 2 quarters. The position peaked at $1.8M in Q2 2023. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • CenterStar Asset Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • CenterStar Asset Management sold 3,448 Thermo Fisher Scientific shares in Q3 2023, an estimated $1.84M.
  • CenterStar Asset Management first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 2 quarters.
  • CenterStar Asset Management's Thermo Fisher Scientific position peaked at $1.8M in Q2 2023.
  • 2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on CenterStar Asset Management's 13F filing for Q3 2023, filed 19 Oct 2023.